Paishuning (Senaparib) – Ovarian Cancer | HongKong DengYue Medicine
- Generic Name/Brand Name: Senaparib / Paishuning®
- Indications: Ovarian Cancer
- Dosage Form: Capsule
- Specification: 20 mg × 75 capsules/box
Senaparib Application Scope
Indication: Treatment of ovarian cancer in patients with germline or somatic BRCA-mutated advanced or recurrent disease.

SenaparibCharacteristics
-
Ingredients: Senaparib (PARP inhibitor).
-
Properties: Oral, small-molecule PARP inhibitor; blocks DNA repair in tumor cells, leading to cell death.
-
Packaging Specification: 20 mg × 75 capsules/box
-
Storage: Store at 20–25 °C, protect from moisture and light.
-
Expiry Date: As printed on the package.
-
Executive Standard: Per registered product quality standard.
-
Approval Number: As indicated on label.
-
Date of Revision: As printed on package insert.
-
Manufacturer: Beigene / BeiGene Ltd.
Guidelines for the Use of Paishuning
-
Dosage and Administration:
-
Recommended Dose: 20–30 mg/day (depending on regimen and patient tolerance).
-
Administration: Swallow capsules whole; do not chew or crush.
-
Missed Dose: Take as soon as remembered; do not double the next dose.
-
-
Adverse Reactions:
-
Common Adverse Reactions: Nausea, vomiting, fatigue, anemia, thrombocytopenia, leukopenia, diarrhea, decreased appetite.
-
Serious Adverse Reactions: Myelosuppression (severe anemia, thrombocytopenia, neutropenia), secondary malignancies (rare), gastrointestinal toxicity, fatigue.
-
-
Contraindications:
-
Hypersensitivity to it or excipients.
-
Pregnancy and breastfeeding.
-
-
Precautions:
-
Monitor blood counts regularly.
-
Adjust dose for hematologic toxicity.
-
Avoid live vaccines during treatment.
-
Contraception advised during and after therapy.
-
Senaparib Interactions
-
CYP3A inhibitors/inducers may alter it exposure.
-
Co-administration with other myelosuppressive agents may increase hematologic toxicity.
-
Monitor concomitant drugs with narrow therapeutic index.
Note:
- If there is a new packaging for the drug, the new packaging shall prevail. The above information is sourced from DengYue Medicine.
- This content is for reference only. Prescription drugs must be used under a doctor’s guidance and purchased from authorized sources.










Reviews
There are no reviews yet.